Acp-103-048
ClinicalTrials.gov NCT03482882
Research payments
$149,063
Through program year 2020, $149,063 in research payments was reported against Acp-103-048, across 14 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03482882
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $149,063 | 14 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Stuart Isaacson Boca Raton, FL Named on 1 payment
- Daniel Truong Fountain Valley, CA Named on 1 payment
- Jason Aldred Spokane, WA Named on 1 payment
- Ashok Patel Toms River, NJ Named on 1 payment
- Gustavo Alva Costa Mesa, CA Named on 1 payment
- Lara Shirikjian Torrance, CA Named on 1 payment
- Richard Shubin Arcadia, CA Named on 1 payment
- Richard Singer Pembroke Pines, FL Named on 1 payment
- Michael Sauter Johnstown, PA Named on 1 payment
- Bhupat Desai Upland, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.